Clinical Biotechnology,Center for Disease Biology and Integrative Medicine, Graduate School of Medicine,The University of Tokyo Hojo-Tei/Chung Group

Our mission is to establish therapeutic strategies for skeletal disorders based on understanding of mechanisms underlying skeletal development, skeletal metabolism and pathology of skeletal disorders. We explore data-driven studies by omics analysis focusing on epigenome. By integrating with bioengineering, we apply the study for modeling of tissue development, establishment of platform for drug discovery and achievement of regenerative medicine.